

Cover Story
Free
By Matthew Bin Han Ong
Last August, Stephen A. Chagares, a breast surgeon, made an announcement that startled some of his colleagues at New Jersey’s Monmouth Medical Center. At internal meetings and in a press release, Chagares declared that he would perform a robotic mastectomy—a new and relatively untested minimally invasive surgical procedure. According to the press release, his first patient, Yvonne Zucco, 56, was being treated for stage IIa breast cancer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Backlog of work grows at NIH as staff members are being hounded to quit
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- In the Headlines: Could “flooding the zone” drown NIH and cancer centers?
- In the Headlines: What are Jay Bhattacharya’s plans for NIH?
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers